About Coherus Oncology
We are in the business of extending life for patients.
- Industry
- Biotechnology Research
- Company size
- 201-500 employees
- Headquarters
- Redwood City, CA
- Founded
- 2010
- Company type
- Public Company
Coherus Oncology is a fully integrated commercial-stage innovative oncology company with an approved next-generation PD-1 inhibitor, LOQTORZI, and a promising pipeline that includes two mid-stage clinical candidates targeting liver, lung, head & neck, and other cancers. Our strategy is to expand the use of LOQTORZI in NPC and advance the development of new indications for LOQTORZI in combination with both our pipeline candidates as well as our industry partners, driving synergies from proprietary combinations, including first-in-class anticancer agents.
If you are interested in joining a highly innovative and exciting company, please visit our careers webpage at http://www.coherus.com/careers/ for a list of career opportunities.
Specialties
- biotechnology and Immuno-oncology
Company locations
333 Twin Dolphin Drive, Suite 600, Redwood City, CA 94065, US
4014 Camino Ranchero, Unit A, Camarillo, California 93012, US
Locations listed on the company profile. These may include offices outside the United States, and not every location is hiring.
Business areas
- Health Care
- Oncology
- Biotechnology
- Medical
- Manufacturing
- Therapeutics
On LinkedIn
- Followers
- 39,091
- People linked to this company
- 210
People who list this company on LinkedIn, not a verified employee count. Figures reflect the saved company profile.
Funding raised
1,316,667,132 USD
Total reported by Crunchbase, in US dollars. This is funding raised, not company revenue or valuation.
Explore the company
Employer category
Other employer
Estimated from the company profile. This category has not been confirmed by the employer.